Pearl (Los Angeles) announced today that FDA has cleared its AI-powered, real-time pathology detection software Second Opinion.
The system can help dentists accurately identify a broad range of common dental conditions in patient X-rays, according to Pearl. Second Opinion applies computer vision to identify and highlight key pathologic and nonpathologic findings.
Displays are displayed immediately. Dentists get sharper vision, and patients better understand their dentists’ findings.
Because X-rays are a regular part of every dental patient’s experience, the first place most people will encounter the power of medical AI technology will be in their dentist’s chair. Second Opinion’s FDA clearance has made that possible,” said Pearl CEO Ophir Tanz.